Apoptosis mechanisms induced by 15d-PMJ2 in HCT116 colon cancer cells: insights into CHOP10/TRB3/Akt signaling

Agents that stimulate the endoplasmic reticulum (ER) stress pathway are being exploited pharmacologically to induce cancer cell death. Cytotoxic ER stress is typically regulated by the transcription factor, C/EBP homologous protein 10 (CHOP10). Products of CHOP10 transcription include the pro-apoptotic proteins: ER oxidoreductase 1α (ERO1α), death receptor-5 (DR5), and tribbles-related protein 3 (TRB3). Our previous findings showed cell death induced by 15-deoxy- Δ12,14 prostamide J2 (15d-PMJ2) occurred in an ER stress-dependent manner. However, the pathway by which 15d-PMJ2 regulates ER stress-mediated death downstream of CHOP10 has not been identified. Our results demonstrate 5 µM 15d-PMJ2 increased CHOP10 expression and apoptosis in HCT116 colon cancer cells. In cells treated with pharmacological inhibitors of ER stress, 15d-PMJ2-induced apoptosis was reliant upon the ER stress pathway. To investigate the role of CHOP10 and its transcriptional products in apoptosis, genetic deletion of CHOP10 (CHOP10-KO) was performed using the CRISPR/Cas9 system. The apoptotic action of 15d-PMJ2 was blunted in cells lacking CHOP10 expression. The deletion of CHOP10 reduced the expression of DR5, ERO1α, and TRB3 although only the expression of TRB3 was significantly reduced. Therefore, we overexpressed TRB3 in CHOP10-KO cells and observed that the activation of Akt was inhibited and 15d-PMJ2-induced apoptosis was restored. Thus, a mechanism of apoptosis elicited by 15d-PMJ2 includes the stimulation of CHOP10/TRB3/Akt inhibition. Given the important role these signaling molecules play in cancer cell fate, 15d-PMJ2 may be an effective inducer of apoptosis in cancer cells.


Introduction
Cancer is the second most common cause of death in the United States (Siegel et al., 2023).The use of cytotoxic, targeted, and immunostimulatory agents has improved therapeutic outcomes for cancer.In spite of this, novel agents are needed to provide cancer patients with more treatment options and to increase survival rates.
Numerous preclinical and clinical studies have determined that agents targeting the endoplasmic reticulum (ER) stress pathway inhibit the growth and survival of cancer cells (Ladin et al., 2017;Prabhu et al., 2020;Chang et al., 2021;Tian et al., 2021;Botrus et al., 2022).The ER plays an essential role in folding and posttranslational modification of secretory and membrane proteins.Disturbances in ER homeostasis compromise protein folding and initiate ER stress (Boyce and Yuan, 2006;Yadav et al., 2014).To alleviate ER stress, the highly conserved stress proteins, inositol-requiring enzyme 1 (IRE1), protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) and activating transcription factor 6 (ATF6) are activated.Stimulation of these ER sensors prevents protein synthesis, enhances ER chaperone activity, and promotes degradation of misfolded or unfolded proteins to restore ER homeostasis.However, when homeostasis cannot be restored due to ER stress overload, apoptosis is initiated (Boyce and Yuan, 2006;Fu et al., 2021).The apoptotic ER stress pathway is primarily regulated by ER stress sensor-induced expression of CCAAT/ enhancer-binding protein (C/EBP) homologous protein 10 (CHOP10) (Li et al., 2014;Yang et al., 2017;Hu et al., 2019).The transcription factor, CHOP10, increases the synthesis of genes that promote cell death including ER oxidoreductase 1α (ERO1α), death receptor-5 (DR5), and tribbles-related protein 3 (TRB3) (Li et al., 2014).ERO1α is an ER luminal molecule that facilitates protein oxidation, a process that can produce cytotoxic levels of reactive oxygen species (Marciniak et al., 2004;Chen et al., 2015;Ramming et al., 2015).DR5, a member of the tumor necrosis factor (TNF) receptor family, induces apoptosis upon engagement of TNFrelated apoptosis-inducing ligand (TRAIL) (MacFarlane et al., 1997;Yamaguchi and Wang, 2004).TRB3 is an intracellular pseudokinase that was identified as a protein inhibitor of the anti-apoptotic molecule, protein kinase B (PKB)/Akt (Ohoka et al., 2005;Li et al., 2017).
ER stress-dependent death is induced by cannabinoids in different cancer cell types (Salazar et al., 2009;Almada et al., 2017).The cannabinoid chemical class is composed of phytocannabinoids (plant-derived), synthetic cannabinoids, and endocannabinoids (endogenously synthesized cannabinoids), all of which bind to and initiate many of their effects through cell surface cannabinoid receptors (CBR) (Soderstrom et al., 2017;Lu and Mackie, 2021).Cannabinoids and CBRs are components of the endocannabinoid system (ECS) which also includes the proteins involved in cannabinoid synthesis, degradation, and uptake.The ECS is being investigated to uncover its role in physiological processes including cardiovascular and central nervous system homeostasis (Soderstrom et al., 2017;Sierra et al., 2018;Zou and Kumar, 2018).Other research has examined whether components of the ECS can serve as drug targets or pharmacological agents that modulate conditions including pain, inflammation, and cancer (Nagarkatti et al., 2009;Rahn and Hohmann, 2009;Ladin et al., 2016).Significant anti-tumor activity has been observed in cancer cells exposed to phytocannabinoids, synthetic cannabinoids, and endocannabinoids (Ladin et al., 2016;Hinz and Ramer, 2022).Arachidonoyl-ethanolamide (AEA) is an endocannabinoid that causes death of neoplastic cells including breast, endometrial, and skin cancer (De Petrocellis et al., 1998;Soliman et al., 2016;Fonseca et al., 2018).It has been determined that AEA is metabolized by the enzyme, cyclooxygenase-2 (COX-2), to the prostaglandinethanolamides, PGE 2 -EA, PGD 2 -EA and PGF 2 alpha-EA (Yu et al., 1997;Kozak et al., 2002).Our group identified a novel molecule produced from the metabolism of AEA by COX-2 named 15-deoxy-Δ 12,14 prostamide J 2 (15d-PMJ 2 ) (Soliman et al., 2016;Ladin et al., 2017).15d-PMJ 2 activates apoptotic ER stress and ER stress-dependent exposure of damage associated molecular patterns (DAMPs) (Ladin et al., 2022;2017;Elhassanny et al., 2020).The induction of ER stress by 15d-PMJ 2 is primarily mediated by PERK signaling which causes the release of ERresident Ca 2+ and Ca 2+ overload in the mitochondria leading to ER-stress dependent apoptosis (Ladin et al., 2022).15d-PMJ 2induced PERK activation also increases the expression of proapoptotic CHOP10 (Ladin et al., 2017).However, the molecular mechanisms by which CHOP10 stimulates apoptosis in 15d-PMJ 2 treated cells are unclear.The current work aims to identify signaling pathways downstream of CHOP10 that are responsible for the apoptotic effect of 15d-PMJ 2 .By identifying signaling pathways of 15d-PMJ 2 -induced cell death, we will obtain a better understanding of its mechanism of action.This information can be used to increase the probability of achieving positive outcomes in future clinical studies (Editorial, 2010;Lin et al., 2019;Jang et al., 2021).

Cell culture
HCT116 human colon cancer cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA).HCT116 cells were maintained in McCoy's medium [containing 10% of heat-inactivated fetal bovine serum (FBS), penicillin (100 mg/mL), and streptomycin (100 mg/mL)] as recommended by the manufacturer (Sigma Aldrich, St. Louis, MO).

Apoptosis detection
Caspase 3/7 activity was detected in cultured cells plated in white-walled 96-well plates and incubated for 48 h.Culture medium containing the appropriate concentrations of 15d-PMJ 2 was added to the cells for 16 h, the time point of peak caspase 3/7 activity.Caspase-Glo 3/7 reagent (Promega, Madison, WI) was added to each well as directed by the manufacturer and luminescence was detected using the Infinite ® M200 PRO multimode reader (Tecan, Switzerland).The percent from untreated was calculated for each well using the formula, [(sample-untreated) ÷ untreated] x 100 and then the average value of triplicate wells was determined.The data from three independent experiments were analyzed.
Apoptotic cells were also detected using the Apoptotic, Necrotic, and Healthy Cells Quantification Kit (Biotium, Hayward, CA).Briefly, HCT116 cells were treated with 15d-PMJ 2 for 16 h, the time point of maximal Annexin V signal.The cells were detached from the culture dishes, washed twice with phosphate buffer saline (PBS), resuspended in Annexin Binding Buffer containing Annexin V-FITC and ethidium homodimer (EtBr), and then incubated in the dark for 15 min.The samples were diluted with four volumes of Annexin Binding Buffer and analyzed using an Accuri C6 flow cytometer (BD Accuri Cytometer, Ann Arbor, MI) at an excitation wavelength of 488 and 533 ± 30 nm and emission of 565 ± 30 nm.

DNA transfection
CRISPR/Cas9 is a genetic modification system that has been adapted from bacteria (Barrangou et al., 2007).In this system, the Cas9 nuclease is directed by a single guide RNA (sgRNA) to its target DNA sequence where a double-stranded structure is created that becomes cleaved by Cas9 nuclease (Jinek et al., 2012).CHOP10 knockout HCT116 cells were generated using the CRISPR/CAS9 system as directed by the manufacturer (Santa Cruz Biotechnology, Santa Cruz, CA).Briefly, in a 6-well tissue culture dish, 2 × 10 5 cells were seeded in 3 mL of antibiotic-free standard growth medium per well, 24 h prior to transfection.Cells were grown to a 50% confluency.Plasmid DNA/UltraCruz ® Transfection Reagent Complex was added to each well in a dropwise fashion and the cells were then incubated for 72 h.After incubation, successful transfection of CRISPR/Cas9 Plasmid was visually confirmed by detection of the green fluorescent protein (GFP) via fluorescent microscopy.Transfected cells were selected by incubation with puromycin (0.8 μg/mL), and different colonies were isolated to measure CHOP10 protein expression.Cell colonies that demonstrate complete knockout of CHOP10 expression (HCT116 CHOP10-KO) were utilized in subsequent experiments.
For CHOP10 overexpression, HCT116 CHOP10-KO cells were cultured in the appropriate plates and/or culture slides and transfected with human CHOP10 cDNA in the pCMV3-C-OFPSpark vector or pCMV3-C-OFPSpark with no cDNA insert (empty vector) (Sino Biological, Beijing, China) using UltraCruz transfection reagent (Santa Cruz Biotechnology, Santa Cruz, CA).

Immunocytochemistry
DNA transfected cells were treated as indicated and fixed with 2% paraformaldehyde in PBS.The cells were then incubated with permeabilization buffer (0.1% Triton X-100 in PBS) for 10 min and incubated with blocking buffer (1X PBS +3% FBS +0.5% Tween20) for 1 h.The blocked cells were then incubated with the indicated primary antibodies and the appropriate immunofluorescence-tagged secondary antibodies.Images were acquired and analyzed by confocal laser microscopy (ZEISS LSM 700 confocal microscope system).Fluorescence intensity was quantified by utilizing ImageJ software.

Reactive oxygen species detection
Reactive oxidative species (ROS) in cultured cells were measured using the chloromethyl-2′,7′dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA) probe (Life technologies, Grand Island, NY).Cells were loaded with 5 μM CM-H 2 DCFDA in phenol redfree, serum-free medium for 30 min and then treated for 8 h.The cells were trypsinized, reconstituted in serum containing, phenol red-free medium and DCF fluorescence was measured using an Accuri C6 flow cytometer (BD Accuri Cytometers, Ann Arbor, MI) at an excitation wavelength of 488 nm and an emission of 533 ± 30 nm.

Statistical analyses
All data are representative of at least three independent experiments.Data are presented as the mean ± standard error of the mean (SEM).One-or two-way Analysis of Variance (ANOVA) followed by Tukey's or Bonferroni's post hoc analysis was carried out using GraphPad Prism.

Results 15d-PMJ 2 causes ER stress-dependent apoptosis
Previous data from our group demonstrated AEA and its metabolic product, 15d-PMJ 2 , caused apoptosis in melanoma and non-melanoma skin cancer cells through ER stress-stimulated CHOP10 expression (Soliman et al., 2016;Ladin et al., 2017).The current study sought to identify signaling pathways downstream of CHOP10 that initiate this cytotoxic response.To begin this investigation, we determined whether 15d-PMJ 2 caused apoptosis in HCT116 colon cancer cells.The human HCT116 cell line was selected for this study because it contains mutations in common driver genes (e.g., KRAS and PIK3CA) that serve as targets of contemporary drug development programs (Cancer Genome Atlas Network, 2012;Ahmed et al., 2013).The cells were treated with different concentrations of 15d-PMJ 2 and then two wellestablished indicators of apoptosis, caspase 3/7 activity and phosphatidyl serine exposure, were detected.15d-PMJ 2 increased caspase 3/7 activity by approximately 200% and 300% in cells treated with 2.5 µM and 5.0 µM of 15d-PMJ 2 , respectively (Figure 1A).15d-PMJ 2 also caused a concentration-dependent increase in percentage of early (Annexin V + /PI − ) and late (Annexin V + /PI + ) stage apoptotic cells with 5 µM 15d-PMJ 2 increasing the total annexin-V positive cell population by more than 60% (Figures 1B, C).
According to our previous melanoma and non-melanoma skin cancer cell studies, PERK-mediated ER stress was the primary molecular pathway of 15d-PMJ 2 -induced apoptosis (Ladin et al., 2022;2017).During ER stress, PERK undergoes homodimerization and autophosphorylation to assume an activated state.Activated PERK phosphorylates eIF2a, an enzyme that resolves ER stress by inhibiting global translation.In HCT116 cells, ER stress was activated by 15d-PMJ 2 as demonstrated by increased phosphorylation of both eIF2α and PERK (Figure 1D).To evaluate whether ER stress was necessary for apoptosis, ER stress activation was inhibited by pre-treating the cells with the pharmacological ER stress inhibitors, salubrinal and 4phenylbutrate (PBA).Salubrinal is a selective inhibitor of the phosphatase, PP1/GADD34 (Boyce et al., 2005).The inhibition of PP1/GADD34 activity prevents the dephosphorylation of phospho-eIF2α, thereby sustaining the translational block and averting ER stress.In contrast, PBA suppresses ER stress by behaving as a chemical chaperone that facilitates protein folding (de Almeida et al., 2007).Blockade of ER stress signaling with salubrinal or PBA suppressed 15d-PMJ 2 -induced caspase 3/7 activity (Figure 1E).Both inhibitors also blocked ER stress-dependent apoptosis induced by the prototype ER stress inducing agent, thapsigargin (Figure 1E).This indicates, ER stress also plays a prominent role in 15d-PMJ 2 -induced apoptosis in HCT116 cells.

CHOP10 triggers apoptosis induced by 15d-PMJ 2
When ER stress cannot be resolved, the expression of the transcription factor, CHOP10, is upregulated.CHOP10 transactivates proteins that propagate apoptotic signals, including ERO1α, DR5, and TRB3 (Li et al., 2014;Yang et al., 2017;Hu et al., 2019).Similar to our findings in B16F10 melanoma cells, CHOP10 expression in HCT116 cells was at its peak 8 h after exposure to 15d-PMJ 2 .To identify pathways by which CHOP10 regulates cell death induced by 15d-PMJ 2 , CHOP10 expression was disabled by employing the CRISPR/Cas9 system.We validated that the expression of CHOP10 was inhibited by exposing HCT116 CHOP10 knockout (CHOP10-KO) and wild-type (WT) cells to 15d-PMJ 2 and detecting CHOP10 expression by western blot analysis (Figure 2A).Consistent with this result, 15d-PMJ 2 -induced caspase 3/7 activity was inhibited by more than 50% in CHOP10-KO compared to WT cells (Figure 2B).Moreover, fewer annexin V positive cells were observed in 15d-PMJ 2 -treated cells that were devoid of CHOP10 than in cells containing CHOP10 (Supplementary Figure S1).These data indicate CHOP10 is needed to elicit a robust apoptotic response to 15d-PMJ 2 .
To identify transcriptional targets of CHOP10 that are pivotal for 15d-PMJ 2 -induced apoptosis, we measured the expression and activity of ERO1α, DR5, and TRB3 in WT and CHOP10-KO cells (Figures 2C-F).ERO1α is an enzyme that promotes protein folding by facilitating disulfide bond formation, but it can also produce cytotoxic oxidative stress levels as a reaction by-product (Marciniak et al., 2004;Chen et al., 2015;Ramming et al., 2015).DR5 is a member of the death receptor family that initiates extrinsic apoptotic signaling by stimulating the cleavage of caspase 8 (MacFarlane et al., 1997;He et al., 2002;Yamaguchi and Wang, 2004).The pseudokinase TRB3, triggers cell death by suppressing the activity of the pro-survival kinase, Akt (Ohoka et al., 2005;Li et al., 2017).In 15d-PMJ 2 treated cells, the loss of CHOP10 caused a reduction in the expression of ERO1α, DR5, and TRB3 although only the reduction in TRB3 expression was statistically significantly (Figures 2C, D).Next, we examined the effect of CHOP10 on the activity of ERO1α, DR5, and TRB3 in 15d-PMJ 2 -treated cells.Oxidative stress, a by-product of ERO1α activity, was suppressed in cells with disrupted CHOP10 expression compared with intact CHOP10 expression (Figure 2E).Cleaved caspase 8, a mediator of the apoptotic effect of DR5, was upregulated in 15d-PMJ 2 -treated cells with, but not cells without, CHOP10 expression (Figure 2F).In 15d-PMJ 2 -treated cells, CHOP10 containing, but not CHOP10 deficient, cells showed an increase in TRB3 activity, detected as reduced Akt phosphorylation (Figure 2F).These collective data suggest CHOP10, and its down-stream effectors propagate apoptotic signaling induced by 15d-PMJ 2 .
CRISPR/Cas9 is a highly effective method for knocking down gene expression with minimal off-target effects.However, to verify that the CRISPR/Cas9 constructs targeted CHOP10 but not offtarget genes, we restored CHOP10 expression by transfecting CHOP10-KO cells with a mammalian expression vector containing CHOP10 cDNA (or the corresponding empty vector).
In 15d-PMJ 2 -treated cells that contained CHOP10, the expression of ERO1α, DR5, and TRB3 was significantly increased compared to cells containing the empty vector (Figure 3A).Additionally, the expression of CHOP10 in CHOP10-KO cells increased caspase 3/ 7 activity after cell exposure to 15d-PMJ 2 (Figure 3B).This suggests CRISPR/Cas9 specifically targeted CHOP10 and that stimulation of ERO1α, DR5, and TRB3 expression and apoptosis in 15d-PMJ 2treated cells was mediated by CHOP10.

TRB3 stimulates 15d-PMJ 2 -induced apoptosis downstream of CHOP10
Our data in Figure 2C show both endogenous and 15d-PMJ 2induced expression of TRB3 was significantly decreased in CHOP10 deficient compared to CHOP10 containing cells.This suggests TRB3 may have a critical role in executing CHOP10mediated apoptosis in response to 15d-PMJ 2 .To examine this signaling pathway in greater detail, TRB3 expression was restored in CHOP10-KO cells by transfecting the cells with a DNA vector containing TRB3 cDNA.In CHOP10-KO cells that were treated with 15d-PMJ 2 , expression of TRB3 suppressed the phosphorylation of Akt (Figure 4A).In line with the reduction in Akt activation, transfection of the TRB3-containing plasmid, but not the empty vector, increased caspase 3/7 activity in 15d-PMJ 2 -treated CHOP10-KO cells with levels comparable to 15d-PMJ 2 -treated WT cells (Figure 4B).This implies that a mechanism of 15d-PMJ 2 -induced apoptosis in HCT116 cells includes the ER stress dependent activation of CHOP10 which causes the upregulation of TRB3, an inhibitor of the anti-apoptotic protein, Akt (Figure 4C).

Discussion
The current study was undertaken to gain an understanding of molecular pathways by which CHOP10 causes apoptosis in 15d-PMJ 2 -treated tumor cells.We determined 15d-PMJ 2 activated CHOP10 and its transcriptional product, TRB3, which led to the inhibition of the anti-apoptotic protein, Akt.These findings reveal an important pathway of 15d-PMJ 2 -induced cell death.
It is well documented that the transcription factor, CHOP10, plays a pivotal role in the switch between the ER stress survival and death pathways (Ma et al., 2002;Li et al., 2014;Yang et al., 2017).Our data indicates CHOP10 also regulates the apoptotic properties of 15d-PMJ 2 .In HCT116 colon cancer cells, 15d-PMJ 2 increased the expression of CHOP10 and the activation of apoptosis in a concentration-dependent manner.However, the apoptotic activity of 15d-PMJ 2 was suppressed in cells that lacked CHOP10 while restoration of CHOP10 expression reinstated apoptosis.These findings agree with our previous data showing 15d-PMJ 2 increased CHOP10 expression and cell death in melanoma and NMSC cells (Ladin et al., 2022;2017).Moreover, AEA and PMD 2 , two pro-apoptotic molecules that are catabolized to 15d-PMJ 2 in tumor cells that overexpress COX-2, also upregulated CHOP10 expression and apoptosis (Soliman et al., 2016;Elhassanny et al., 2019).Other groups have demonstrated CHOP10 dictates cell fate during ER stress.For example, Lin et al. (2013) showed that capsaicin-induced expression of CHOP10 caused apoptosis in pancreatic cancer cells and that this effect was suppressed by siRNA-mediated downregulation of CHOP10.Also, apoptosis induced by tunicamycin was prevented by blocking the expression of CHOP10 in hepatocellular carcinoma (Lei et al., 2017).Hence, CHOP10 is an important stimulus for initiating apoptosis and agents that trigger its synthesis may be useful components of cancer chemotherapeutic regimens.
Although it is clear that CHOP10 causes apoptosis in response to 15d-PMJ 2 exposure, the molecular mechanism behind this effect had not been elucidated.Having knowledge about mechanisms of 15d-PMJ 2 -induced cell death can improve the outcome of future clinical studies by allowing the prediction of agent activities including the modes of toxicity and resistance (Editorial, 2010;Lin et al., 2019;Jang et al., 2021).It can also facilitate the discovery of predictive biomarkers, the identification of new drug targets, and the selection of coadministered agents (Editorial, 2010;Davis, 2020).Therefore, as part of our effort to develop 15d-PMJ 2 as a cancer therapeutic, the current study examined methods of 15d-PMJ 2 apoptosis.Operating under the knowledge that CHOP10 can transcriptionally activate the proapoptotic proteins, ERO1α, DR5, and TRB3, we examined the expression of these molecules.In 15d-PMJ 2 treated cells, the loss of CHOP10 caused a significant reduction in the expression of TRB3 but not ERO1α or DR5.This indicated the potential relevance of TRB3 in the activity of 15d-PMJ 2 .To examine the effect of TRB3 in greater detail, HCT116 CHOP10-KO cells were transfected with an expression vector containing TRB3 and then treated with 15d-PMJ 2 .Under these conditions, TRB3 suppressed Akt activation and restored apoptosis implying CHOP10/TRB3/Akt inhibition triggered apoptosis.Apoptotic cell death was also mediated by CHOP10/TRB3/Akt inhibition in prostate cancer cells treated with the agent, corosolic acid (Ma et al., 2018).These outcomes are in alignment with data showing TRB3 inhibits Akt through an interaction that hinders Akt phosphorylation and activation (Du et al., 2003).It is also wellknown that the blockade of Akt activity stimulates apoptosis by inhibiting anti-apoptotic proteins (Datta et al., 1997).Therefore, it was not surprising that TRB3 expression and the subsequent inactivation of Akt in CHOP10-KO cells restored the apoptotic activity of 15d-PMJ 2 .Since 15d-PMJ 2 inhibits Akt and activates ER stress, this suggests 15d-PMJ 2 may enhance the anti-tumor activity of FDA approved cancer therapeutics.For instance, the ER stress inhibitor, salubrinal, promoted differentiation of colon cancer stem cells thereby sensitizing them to the cytotoxic effect of the colon cancer drug, oxaliplatin (Wielenga et al., 2015).The agent, GSK690693, which blocks Akt activity, caused a significant increase in the cytotoxicity of irinotecan compared to cells treated with GSK690693 or irinotecan alone (Pradeepa et al., 2022).As such, our future studies will investigate the cytotoxic effects of combination therapy with 15d-PMJ 2 .
Previous work from our group demonstrated that 15d-PMJ 2 activated the ER stress response primarily through PERK, but not ATF6 or IRE1 signaling (Ladin et al., 2022).Moreover, ER stressdependent Ca 2+ mobilization from the ER to the mitochondria played a crucial role in mPTP-driven apoptosis.Although our collective research has uncovered important mechanisms of 15d-PMJ 2 activity upstream of CHOP10, we have not identified the specific molecule(s) that interact with 15d-PMJ 2 to initiate ER stress and apoptosis.Having a detailed knowledge of both the molecular target(s) and activities of 15d-PMJ 2 will permit us to apply this information towards the development of optimized therapeutic regimens and as such, our efforts are focused on these topics.
The current study investigated mechanisms of 15d-PMJ 2induced apoptosis as part of our assessment of its activity and chemotherapeutic potential.We determined 15d-PMJ 2 caused tumor cell apoptosis through the activation of ER stress and CHOP10.The activity of CHOP10 stimulated TRB3 expression which led to the inhibition of the pro-survival kinase, Akt.This identifies CHOP10/TRB3/Akt inhibition as vital for the effects of 15d-PMJ 2, and it reveals a molecular mechanism underpinning the activity of 15d-PMJ 2 .By stimulating this signaling pathway, 15d-PMJ 2 may provide an effective strategy for killing cancer cells.

Limitations of the study
Although we have uncovered signaling pathways involved in 15dPMJ 2 -induced apoptosis, there are two notable shortcomings in this study that are being addressed in our current and upcoming work.First, 15d-PMJ 2 -induced apoptotic signaling was examined in wild-type HCT116 and CHOP10-KO HCT116 human cell lines, but not in additional cancer cell types.To obtain a clear picture of the signaling pathways that lead to death in other cell lines, a complete loss of CHOP10 function is essential.Pharmacological inhibitors that selectively target CHOP10 are not readily available, but the current study and other reports (Guo et al., 2021) demonstrate CRISPR/Cas9 gene editing allows the identification of signaling pathways that are downstream of CHOP10.Using this strategy, we will knockout the CHOP10 gene in different cell lines to investigate pathways utilized by 15d-PMJ 2 to elicit cell death.Second, the in vitro activity of 15d-PMJ 2 was investigated without examining its action an animal tumor model.Previous work from our group demonstrated 15d-PMJ 2 inhibited the growth of B16F10 melanoma in C57BL/6 mice (Ladin et al., 2017).We will examine the activity of 15d-PMJ 2 by implanting cell lines with genetically ablated CHOP10 into the subcutaneous flank of immunocompromised mice.These studies will provide a comprehensive understanding of CHOP10-mediated signaling and the therapeutic potential of 15d-PMJ 2 .

FIGURE 3
FIGURE 3 Restoration of CHOP10 expression in CHOP10-KO cells increases the synthesis of ERO1α, DR5, and TRB3 and the activation of apoptosis after exposure to 15d-PMJ 2 .(A,B) pCMV3-OFP-or CHOP10-pCMV3-OFP-transfected CHOP10-KO cells were treated with 5 µM 15d-PMJ 2 or vehicle.(A) The expression of ERO1α, DR5, and TRB3 was detected by performing immunofluorescence staining and visualizing the images using confocal microscopy.Green fluorescence represents ERO1α, DR5, or TRB3, red fluorescence represents CHOP10 or empty OFP vector, and blue fluorescence represents the nucleus (DAPI staining).Histograms show quantification of the intensity of ERO1α, DR5, and TRB3.(B) Apoptosis measurement was performed using caspase 3/7 activity assays.The data were analyzed using two-way ANOVA followed by Bonferroni's multiple comparison post-test and are presented as the mean ± SEM of three independent experiments.***p < 0.001 when comparing samples to vehicle-treated cells.###p < 0.001 when comparing samples to 15d-PMJ 2 -treated cells.